Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Unknown 8Terminated 4Recruiting 4Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 3Stomach Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Neoplasm Metastasis 1HIPEC 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Paclitaxel 3Cytoreduction Surgical Procedures 2tremelimumab 1soluble LAG-3 protein, human 1sodium thiosulfate 1relacorilant 1oregovomab 1olaparib 1avelumab 1Taxes 1Observation 1Leucovorin 1Hyperthermic Intraperitoneal Chemotherapy 1Fluorouracil 1Cisplatin 1Cell Count 1Carboplatin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Peritoneal Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03348150 2025-07-17

PERISCOPEII

The Netherlands Cancer Institute

Phase 3 Active not recruiting
102 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡